GlycoMimetics to Present at Jefferies 2021 Virtual Healthcare Conference
May 27 2021 - 6:08PM
Business Wire
GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that Chief
Executive Officer Rachel King will provide a company overview at
the Jefferies 2021 Virtual Healthcare Conference. Ms. King’s
presentation will take place from 2:30 to 2:55 p.m. on June 3,
2021. More information is available in the Investors section of the
GlycoMimetics website.
About GlycoMimetics, Inc.
GlycoMimetics is a clinical-stage biotechnology company
discovering and developing glycobiology-based therapies for
cancers, including acute myeloid leukemia (AML) and breast cancer,
and other inflammatory diseases with high unmet need. Our science
is based on an understanding of the role that carbohydrates play on
the surface of every living cell and applying our specialized
chemistry platform to discover small molecule drugs, known as
glycomimetics, that alter these carbohydrate-mediated pathways in a
variety of disease states, including signaling in cancer and
inflammation. As a leader in this space, we are leveraging this
unique targeted approach to advance our pipeline of wholly owned
drug candidates, with the goal of developing transformative
therapies for serious diseases. Our leading drug candidate,
uproleselan, has received Breakthrough Therapy Designation in the
U.S. and China and is undergoing evaluation across a range of
patient populations, including a Phase 3 trial in
relapsed/refractory AML. GlycoMimetics is located in Rockville, MD
in the BioHealth Capital Region. Learn more at
www.glycomimetics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210527005938/en/
Investor Contact: Shari Annes Phone: 650-888-0902 Email:
sannes@annesassociates.com Media Contact: Jamie Lacey-Moreira
Phone: 410-299-3310 Email: jamielacey@presscommpr.com
GlycoMimetics (NASDAQ:GLYC)
Historical Stock Chart
From Apr 2024 to May 2024
GlycoMimetics (NASDAQ:GLYC)
Historical Stock Chart
From May 2023 to May 2024